Back to User profile » Prof. Dr. Fabio Piscaglia
Papers published by Prof. Dr. Fabio Piscaglia:
HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients
Indre MG, Stefanini B, Boe M, Capelli R, Chen R, Abbati C, Santangeli E, Salamone A, Girolami F, Tovoli F, Morelli MC, Piscaglia F, Ferri S, Ravaioli F
Journal of Hepatocellular Carcinoma 2026, 13:561956
Published Date: 22 January 2026
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D’Alessio A
Journal of Hepatocellular Carcinoma 2025, 12:671-683
Published Date: 4 April 2025
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients
Benevento F, Pecorelli A, Stefanescu H, Sparchez Z, Vukotic R, Pettinari I, Grigoras CA, Tovoli F, Ravaioli F, Stefanini B, Andreone P, Piscaglia F
Journal of Hepatocellular Carcinoma 2023, 10:473-482
Published Date: 27 March 2023
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
Fornari F, Giovannini C, Piscaglia F, Gramantieri L
Journal of Hepatocellular Carcinoma 2022, 9:1263-1278
Published Date: 8 December 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
Burgio V, Iavarone M, Di Costanzo GG, Marra F, Lonardi S, Tamburini E, Piscaglia F, Masi G, Celsa C, Foschi FG, Silletta M, Amoruso DC, Rimini M, Bruccoleri M, Tortora R, Campani C, Soldà C, Viola MG, Forgione A, Conti F, Salani F, Catanese S, Giacchetto CM, Fulgenzi C, Coppola C, Lampertico P, Pellino A, Rancatore G, Cabibbo G, Ratti F, Pedica F, Della Corte A, Colombo M, De Cobelli F, Aldrighetti L, Cascinu S, Casadei-Gardini A
Cancer Management and Research 2021, 13:9379-9389
Published Date: 24 December 2021
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
Fornari F, Giovannini C, Piscaglia F, Gramantieri L
Journal of Hepatocellular Carcinoma 2021, 8:741-757
Published Date: 2 July 2021
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC
Granito A, Marinelli S, Forgione A, Renzulli M, Benevento F, Piscaglia F, Tovoli F
Journal of Hepatocellular Carcinoma 2021, 8:477-492
Published Date: 26 May 2021
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
Gramantieri L, Giovannini C, Piscaglia F, Fornari F
Journal of Hepatocellular Carcinoma 2021, 8:369-385
Published Date: 12 May 2021